» Articles » PMID: 31055947

Patient Perception and Satisfaction With Insulin Pump System: Pilot User Experience Survey

Overview
Specialty Endocrinology
Date 2019 May 7
PMID 31055947
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The goal of this study was to assess patient perspectives and satisfaction with the MiniMed 670G insulin pump. Those participants who used the pump as part of a hybrid closed loop were also asked to provide their views on the automatic feature (auto mode).

Methods: Adults with type 1 diabetes mellitus using the Medtronic™ 670G pump were asked about their experience with the device using a semi-structured survey developed by the research team. Responses were quantified to identify emergent themes.

Results: Seventeen participants used the pump as part of a hybrid closed loop system, while four participants used the pump in combination with a nonintegrated continuous glucose monitoring system. Overall, participants indicated a high level of satisfaction with the pump (14/21) mostly because of improvements in blood glucose (BG) control (15/21). Least liked features were physical design and structure (6/21), frequency of user input (5/21), alert frequency (4/21), and difficulty of use (3/21). Those using the hybrid closed loop were satisfied with the auto mode feature (11/17), mostly because of improvements in BG control (9/17). The least liked features of the auto mode technology were that blood glucose levels remained elevated (5/17) and the frequency of alerts (4/17).

Conclusion: Participants indicated a high level of satisfaction with the pump and its auto mode featured mostly because of improvements in BG control. They also pointed out some key aspects of the device that are of potential clinical or commercial relevance. Additional research is needed to further evaluate users' perspectives on this new device.

Citing Articles

Future acceptance of automated insulin delivery systems in youths with type 1 diabetes: validation of the Italian artificial pancreas-acceptance measure.

Franceschi R, Pertile R, Marigliano M, Mozzillo E, Maffeis C, Zaffani S Acta Diabetol. 2024; 62(2):177-183.

PMID: 39126517 PMC: 11861114. DOI: 10.1007/s00592-024-02327-9.


Patient experiences of continuous glucose monitoring and sensor-augmented insulin pump therapy for diabetes: A systematic review of qualitative studies.

Natale P, Chen S, Chow C, Cheung N, Martinez-Martin D, Caillaud C J Diabetes. 2023; 15(12):1048-1069.

PMID: 37551735 PMC: 10755613. DOI: 10.1111/1753-0407.13454.


A Systematic Review of Commercial Hybrid Closed-Loop Automated Insulin Delivery Systems.

Peacock S, Frizelle I, Hussain S Diabetes Ther. 2023; 14(5):839-855.

PMID: 37017916 PMC: 10126177. DOI: 10.1007/s13300-023-01394-5.


Patient Satisfaction with a Dedicated Infusion Pump for Subcutaneous Treprostinil to Treat Pulmonary Arterial Hypertension.

Waligora M, Zulawinska B, Tomaszewski M, Roset P, Kopec G J Pers Med. 2023; 13(3).

PMID: 36983605 PMC: 10058864. DOI: 10.3390/jpm13030423.


Data-Driven Diabetes Education Guided by a Personalized Report for Patients on Insulin Pump Therapy.

Groat D, Corrette K, Grando A, Vellore V, Bayuk M, Karway G ACI open. 2021; 4(1):e9-e21.

PMID: 34169229 PMC: 8221578. DOI: 10.1055/s-0039-1701022.


References
1.
Rodbard D . Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes. Diabetes Technol Ther. 2017; 19(S3):S25-S37. PMC: 5467105. DOI: 10.1089/dia.2017.0035. View

2.
Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S . Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med. 2013; 368(9):824-33. DOI: 10.1056/NEJMoa1206881. View

3.
Hermanides J, Norgaard K, Bruttomesso D, Mathieu C, Frid A, Dayan C . Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial. Diabet Med. 2011; 28(10):1158-67. DOI: 10.1111/j.1464-5491.2011.03256.x. View

4.
Polonsky W, Fisher L, Hessler D, Edelman S . Development of a New Measure for Assessing Insulin Delivery Device Satisfaction in Patients with Type 1 and Type 2 Diabetes. Diabetes Technol Ther. 2015; 17(11):773-9. DOI: 10.1089/dia.2015.0140. View

5.
Stewart Z, Wilinska M, Hartnell S, Temple R, Rayman G, Stanley K . Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes. N Engl J Med. 2016; 375(7):644-54. DOI: 10.1056/NEJMoa1602494. View